{"data":[{"accessionNo":"0002086358-26-000006","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001006281","issuerName":"Protalix BioTherapeutics, Inc.","ticker":"PLX","cusip":"74365A309","securityClass":"Common Shares","eventDate":"2026-10-14","reportingPerson":"HOLD Alapkezelo Zrt.","reportingCik":null,"personType":"OO","sharesOwned":4157791,"percentOfClass":5.2,"filedAt":"2026-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/plx"},{"accessionNo":"0002012383-26-002863","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001006281","issuerName":"PROTALIX BIOTHERAPEUTICS INC","ticker":"PLX","cusip":"74365A309","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":4046650,"percentOfClass":5.02,"filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/plx"},{"accessionNo":"0001426156-26-000006","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001006281","issuerName":"Protalix BioTherapeutics, Inc.","ticker":"PLX","cusip":"74365A309","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-24","reportingPerson":"Kaufman Michael A","reportingCik":null,"personType":"IN","sharesOwned":3616289,"percentOfClass":4.5,"filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/plx"},{"accessionNo":"0001426156-26-000006","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001006281","issuerName":"Protalix BioTherapeutics, Inc.","ticker":"PLX","cusip":"74365A309","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-24","reportingPerson":"MAK CAPITAL ONE LLC","reportingCik":null,"personType":"IA","sharesOwned":3616289,"percentOfClass":4.5,"filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/plx"},{"accessionNo":"0001426156-26-000006","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001006281","issuerName":"Protalix BioTherapeutics, Inc.","ticker":"PLX","cusip":"74365A309","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-24","reportingPerson":"MAK Capital Fund LP","reportingCik":null,"personType":"PN","sharesOwned":3616289,"percentOfClass":4.5,"filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/plx"},{"accessionNo":"0001426156-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001006281","issuerName":"Protalix BioTherapeutics, Inc.","ticker":"PLX","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-02-26","reportingPerson":"MAK Capital Fund LP","reportingCik":null,"personType":"PN","sharesOwned":4649599,"percentOfClass":5.8,"filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/plx"},{"accessionNo":"0001426156-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001006281","issuerName":"Protalix BioTherapeutics, Inc.","ticker":"PLX","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-02-26","reportingPerson":"MAK CAPITAL ONE LLC","reportingCik":null,"personType":"IA","sharesOwned":4649599,"percentOfClass":5.8,"filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/plx"},{"accessionNo":"0001426156-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001006281","issuerName":"Protalix BioTherapeutics, Inc.","ticker":"PLX","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-02-26","reportingPerson":"Kaufman Michael A","reportingCik":null,"personType":"IN","sharesOwned":4649599,"percentOfClass":5.8,"filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/plx"}],"updatedAt":"2026-10-24T09:33:49.694Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/plx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}